Annual Working Capital
$125.55 M
-$40.11 M-24.21%
December 31, 2023
Summary
- As of February 7, 2025, ALDX annual working capital is $125.55 million, with the most recent change of -$40.11 million (-24.21%) on December 31, 2023.
- During the last 3 years, ALDX annual working capital has risen by +$54.90 million (+77.71%).
- ALDX annual working capital is now -43.18% below its all-time high of $220.98 million, reached on December 31, 2021.
Performance
ALDX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$99.57 M
+$1.51 M+1.54%
September 30, 2024
Summary
- As of February 7, 2025, ALDX quarterly working capital is $99.57 million, with the most recent change of +$1.51 million (+1.54%) on September 30, 2024.
- Over the past year, ALDX quarterly working capital has dropped by -$26.03 million (-20.72%).
- ALDX quarterly working capital is now -59.99% below its all-time high of $248.85 million, reached on June 30, 2021.
Performance
ALDX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ALDX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.2% | -20.7% |
| 3 y3 years | +77.7% | -57.6% |
| 5 y5 years | +45.5% | +53.4% |
ALDX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.2% | at low | -54.9% | +1.5% |
| 5 y | 5-year | -43.2% | +101.7% | -60.0% | +72.1% |
| alltime | all time | -43.2% | +5469.3% | -60.0% | +6701.5% |
Aldeyra Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $99.57 M(+1.5%) |
| Jun 2024 | - | $98.05 M(-17.7%) |
| Mar 2024 | - | $119.17 M(-5.1%) |
| Dec 2023 | $125.55 M(-24.2%) | $125.55 M(-0.0%) |
| Sep 2023 | - | $125.59 M(-10.2%) |
| Jun 2023 | - | $139.87 M(-8.0%) |
| Mar 2023 | - | $152.01 M(-8.2%) |
| Dec 2022 | $165.66 M(-25.0%) | $165.66 M(+0.2%) |
| Sep 2022 | - | $165.29 M(-10.4%) |
| Jun 2022 | - | $184.50 M(-10.4%) |
| Mar 2022 | - | $206.00 M(-6.8%) |
| Dec 2021 | $220.98 M(+212.8%) | $220.98 M(-5.9%) |
| Sep 2021 | - | $234.83 M(-5.6%) |
| Jun 2021 | - | $248.85 M(+83.0%) |
| Mar 2021 | - | $135.98 M(+92.5%) |
| Dec 2020 | $70.65 M(+13.5%) | $70.65 M(-13.6%) |
| Sep 2020 | - | $81.73 M(+22.9%) |
| Jun 2020 | - | $66.50 M(+14.9%) |
| Mar 2020 | - | $57.86 M(-7.1%) |
| Dec 2019 | $62.26 M(-27.9%) | $62.26 M(-4.1%) |
| Sep 2019 | - | $64.90 M(-2.4%) |
| Jun 2019 | - | $66.47 M(-14.2%) |
| Mar 2019 | - | $77.50 M(-10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $86.30 M(+112.5%) | $86.30 M(+195.6%) |
| Sep 2018 | - | $29.19 M(-22.7%) |
| Jun 2018 | - | $37.76 M(+2.2%) |
| Mar 2018 | - | $36.94 M(-9.0%) |
| Dec 2017 | $40.61 M(+77.9%) | $40.61 M(-12.9%) |
| Sep 2017 | - | $46.63 M(+92.5%) |
| Jun 2017 | - | $24.23 M(-16.6%) |
| Mar 2017 | - | $29.06 M(+27.3%) |
| Dec 2016 | $22.83 M(-12.1%) | $22.83 M(-13.8%) |
| Sep 2016 | - | $26.49 M(-13.0%) |
| Jun 2016 | - | $30.44 M(+41.5%) |
| Mar 2016 | - | $21.50 M(-17.2%) |
| Dec 2015 | $25.97 M(+249.5%) | $25.97 M(-13.0%) |
| Sep 2015 | - | $29.85 M(-8.0%) |
| Jun 2015 | - | $32.45 M(+118.3%) |
| Mar 2015 | - | $14.86 M(+100.0%) |
| Dec 2014 | $7.43 M(+178.8%) | $7.43 M(-21.8%) |
| Sep 2014 | - | $9.50 M(-10.7%) |
| Jun 2014 | - | $10.63 M(+626.2%) |
| Mar 2014 | - | $1.46 M(-45.1%) |
| Dec 2013 | $2.67 M(+65.2%) | $2.67 M(+3.8%) |
| Sep 2013 | - | $2.57 M(+59.1%) |
| Dec 2012 | $1.61 M(-169.0%) | $1.61 M |
| Dec 2011 | -$2.34 M | - |
FAQ
- What is Aldeyra Therapeutics annual working capital?
- What is the all time high annual working capital for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual working capital year-on-year change?
- What is Aldeyra Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly working capital year-on-year change?
What is Aldeyra Therapeutics annual working capital?
The current annual working capital of ALDX is $125.55 M
What is the all time high annual working capital for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual working capital is $220.98 M
What is Aldeyra Therapeutics annual working capital year-on-year change?
Over the past year, ALDX annual working capital has changed by -$40.11 M (-24.21%)
What is Aldeyra Therapeutics quarterly working capital?
The current quarterly working capital of ALDX is $99.57 M
What is the all time high quarterly working capital for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly working capital is $248.85 M
What is Aldeyra Therapeutics quarterly working capital year-on-year change?
Over the past year, ALDX quarterly working capital has changed by -$26.03 M (-20.72%)